The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis

BACKGROUND: Whether portal hypertension (PHT) is an appropriate contraindication for hepatic resection (HR) in hepatocellular carcinoma (HCC) patient is still under debate. Aims: Our aim was to assess the impact of clinically significant PHT on postoperative complication and prognosis in HCC patient...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Wei, Zeng, Qingli, Zheng, Yun, Chen, Meixian, Shen, Jingxian, Qiu, Jiliang, Chen, Miao, Zou, Ruhai, Liao, Yadi, Li, Qijiong, Wu, Xianqiu, Li, Binkui, Yuan, Yunfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399206/
https://www.ncbi.nlm.nih.gov/pubmed/25886495
http://dx.doi.org/10.1186/s12885-015-1280-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4399206/
https://www.ncbi.nlm.nih.gov/pubmed/25886495
http://dx.doi.org/10.1186/s12885-015-1280-3

Ejemplares similares